Monitoring Patients With Dementia: Insight Into Global Trends, Innovations, and Future Directions

참고문헌 (12)

1. Wolters FJ, "Twenty-seven-year time trends in dementia incidence in Europe and the United States : the Alzheimer cohorts consortium", Neurology, 95, pp.e519~e531 (2020)
2. Kwon HS, "Annual incidence of dementia from 2003 to 2018 in metropolitan Seoul, Korea : a population-based study", J Clin Med, 11, pp.819~ (2022)
3. GBD 2019 Dementia Forecasting Collaborators, "Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050 : an analysis for the global burden of disease study 2019", Lancet Public Health, 7, pp.e105~e125 (2022)
4. van Dyck CH, "Lecanemab in early Alzheimer’s disease", N Engl J Med, 388, pp.9~21 (2023)
5. Sims JR, "Donanemab in early symptomatic Alzheimer disease : the TRAILBLAZER-ALZ 2 randomized clinical trial", JAMA, 330, pp.512~527 (2023)
6. Kwon HS, "Comparing the characteristics of patients with newly diagnosed dementia before and after 2008 in Seoul, South Korea : a population-based study", J Clin Neurol, 18, pp.711~713 (2022)
7. Kwon HS, "Five-year community management rate for dementia patients : a proposed indicator for dementia policies", J Clin Neurol, 18, pp.24~32 (2022)
8. Kwon HS, "Neuroinflammation in neurodegenerative disorders : the roles of microglia and astrocytes", Transl Neurodegener, 9, pp.42~ (2020)
9. Kwon HS, "Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers", Alzheimers Dement(Amst), 15, pp.e12502~ (2023)
10. Park SA, "Promising blood biomarkers for clinical use in Alzheimer’s disease : a focused update", J Clin Neurol, 18, pp.401~409 (2022)
11. de Souza GS, "amyloid-β PET classification on cognitive aging stages using the Centiloid scale", Mol Imaging Biol, 24, pp.394~403 (2022)
12. Kwon HS, "Predicting cognitive stage transition using p-tau181, Centiloid, and other measures", Alzheimers Dement, 19, pp.4641~4650 (2023)

관련 논문AI추천